BRPI1010809A2 - composto, composição farmacêutica, métodos de tratar câncer em mamífero e usos de compostos e de composição farmacêutica - Google Patents
composto, composição farmacêutica, métodos de tratar câncer em mamífero e usos de compostos e de composição farmacêuticaInfo
- Publication number
- BRPI1010809A2 BRPI1010809A2 BRPI1010809A BRPI1010809A BRPI1010809A2 BR PI1010809 A2 BRPI1010809 A2 BR PI1010809A2 BR PI1010809 A BRPI1010809 A BR PI1010809A BR PI1010809 A BRPI1010809 A BR PI1010809A BR PI1010809 A2 BRPI1010809 A2 BR PI1010809A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical composition
- methods
- mammalian cancer
- treating mammalian
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/09—Pyrimidine radicals with arabinosyl as the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/12—Triazine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/19—Purine radicals with arabinosyl as the saccharide radical
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17743609P | 2009-05-12 | 2009-05-12 | |
| PCT/US2010/034463 WO2010132513A1 (en) | 2009-05-12 | 2010-05-12 | 2'-fluoro arabino nucleosides and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1010809A2 true BRPI1010809A2 (pt) | 2015-10-13 |
Family
ID=43085308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1010809A BRPI1010809A2 (pt) | 2009-05-12 | 2010-05-12 | composto, composição farmacêutica, métodos de tratar câncer em mamífero e usos de compostos e de composição farmacêutica |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20120149657A1 (pt) |
| EP (1) | EP2430034A4 (pt) |
| JP (1) | JP2012526831A (pt) |
| KR (1) | KR20120007077A (pt) |
| CN (1) | CN102459297A (pt) |
| AU (1) | AU2010249119A1 (pt) |
| BR (1) | BRPI1010809A2 (pt) |
| CA (1) | CA2761880A1 (pt) |
| EA (1) | EA201190269A1 (pt) |
| MX (1) | MX2011012068A (pt) |
| WO (1) | WO2010132513A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201610936RA (en) | 2011-12-22 | 2017-02-27 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
| US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| MA41213A (fr) | 2014-12-19 | 2017-10-24 | Alios Biopharma Inc | Nucléosides substitués, nucléotides et analogues de ceux-ci |
| JP6450356B2 (ja) * | 2016-02-29 | 2019-01-09 | 富士フイルム株式会社 | 液状医薬製剤 |
| WO2023178133A1 (en) * | 2022-03-15 | 2023-09-21 | Rome Therapeutics, Inc. | Compounds and methods for treating disease |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4751221A (en) * | 1985-10-18 | 1988-06-14 | Sloan-Kettering Institute For Cancer Research | 2-fluoro-arabinofuranosyl purine nucleosides |
| CN101089010B (zh) * | 1998-02-25 | 2011-12-14 | 埃莫里大学 | 2＇-氟代核苷 |
| ATE344271T1 (de) * | 1998-02-25 | 2006-11-15 | Univ Emory | 2'-fluoronukleoside |
| CN100532388C (zh) * | 2007-07-16 | 2009-08-26 | 郑州大学 | 2’-氟-4’-取代-核苷类似物、其制备方法及应用 |
-
2010
- 2010-05-12 MX MX2011012068A patent/MX2011012068A/es not_active Application Discontinuation
- 2010-05-12 JP JP2012510962A patent/JP2012526831A/ja not_active Withdrawn
- 2010-05-12 AU AU2010249119A patent/AU2010249119A1/en not_active Abandoned
- 2010-05-12 EP EP10775445.9A patent/EP2430034A4/en not_active Withdrawn
- 2010-05-12 CN CN2010800265801A patent/CN102459297A/zh active Pending
- 2010-05-12 BR BRPI1010809A patent/BRPI1010809A2/pt not_active IP Right Cessation
- 2010-05-12 US US13/320,492 patent/US20120149657A1/en not_active Abandoned
- 2010-05-12 WO PCT/US2010/034463 patent/WO2010132513A1/en active Application Filing
- 2010-05-12 CA CA2761880A patent/CA2761880A1/en not_active Abandoned
- 2010-05-12 EA EA201190269A patent/EA201190269A1/ru unknown
- 2010-05-12 KR KR1020117029436A patent/KR20120007077A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2761880A1 (en) | 2010-11-18 |
| US20120149657A1 (en) | 2012-06-14 |
| KR20120007077A (ko) | 2012-01-19 |
| EP2430034A4 (en) | 2013-05-15 |
| EA201190269A1 (ru) | 2012-07-30 |
| EP2430034A1 (en) | 2012-03-21 |
| CN102459297A (zh) | 2012-05-16 |
| JP2012526831A (ja) | 2012-11-01 |
| MX2011012068A (es) | 2012-06-08 |
| WO2010132513A1 (en) | 2010-11-18 |
| AU2010249119A1 (en) | 2011-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012022878A2 (pt) | composto, composição farmacêutica, uso do compostos e método de tratamento | |
| BR112013012309A2 (pt) | composto, composição, métodos de tratamento e usos de um composto | |
| BRPI1013640A2 (pt) | composicao farmaceutica, metodos para o tratamento e usos dos mesmos | |
| BR112013011968A2 (pt) | composição farmacêutica, métodos de tratamento e usos da mesma | |
| BR112012018951A2 (pt) | composição farmacêutica, combinação farmacêutica e método para o tratamento e\ou prevenção de um câncer e anticorpo | |
| BRPI1009372A2 (pt) | compostos, composição farmacêutica e respectivos usos | |
| BR112014002621A2 (pt) | anticorpo, composição farmacêutica, combinação farmacêutica, dna e método de tratamento | |
| BR112013014692A2 (pt) | composto e respectivo processo de preparação e composição farmacêutica | |
| BR112012022879A2 (pt) | composto, composição farmacêutica, uso do composto e método de tratamento | |
| BRPI0908021A2 (pt) | Composto, composição farmacêutica, e, usos do composto ou da composição farmacêutica | |
| BRPI1008566A2 (pt) | métodos e composições para o diagnóstico e tratamento de câncer | |
| BRPI1007477A2 (pt) | método, e, composição de tratamento de poço | |
| BR112012018947A2 (pt) | composição farmacêutica para tratamento e\ou prevenção do cancêr | |
| BR112013033811A2 (pt) | composição, método de preparação da composição, e, composto | |
| BR112012005594A2 (pt) | tratamento de câncer | |
| EP2532364A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF CANCER | |
| BRPI0919238A2 (pt) | métodos e composições para o tratamento de câncer | |
| BRPI1007972A2 (pt) | composições de combinação e métodos para o tratamento de câncer | |
| BRPI0908635A2 (pt) | composto, composição farmacêutica e método de tratamento de câncer | |
| BR112012020585A2 (pt) | composto, composição farmacêutica e método de tratamento de um distúrbio mediado por tirosina quinase | |
| BRPI1008564A2 (pt) | métodos e composições para o dignóstico e tratamento de câncer | |
| BR112014010290A2 (pt) | composição farmacêutica, métodos, composições e usos | |
| BRPI1010874A2 (pt) | composição para o tratamento de câncer de próstata | |
| ITTO20110630A1 (it) | Composizioni farmaceutiche di combinazione e metodo per trattare vertigini, cinetosi e distonia vascolare vegetativa | |
| ITTO20110641A1 (it) | Composizioni farmaceutiche e metodi di trattamento |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2362 DE 12-04-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |